Monoclonal antibodies against GARP/TGF-β1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivo

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

Robert, C., Thomas, L., Bondarenko, I., O'Day, S., Weber, J., Garbe, C., Lebbe, C., Baurain, J.-F., Testori, A., Grob, J.-J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104621 · Cited by 4,496

Nivolumab plus Ipilimumab in Advanced Melanoma

Wolchok, J. D., Kluger, H., Callahan, M. K., Postow, M. A., Rizvi, N. A., Lesokhin, A. M., Segal, N. H., Ariyan, C. E., Gordon, R.-A., Reed, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302369 · Cited by 4,230

TGFβ in Cancer

Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907

Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease

Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985

Regulatory T cells: mechanisms of differentiation and function

Josefowicz, S. Z., Lu, L.-F., & Rudensky, A. Y. (2012) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141623 · Cited by 2,866

FOXP3+ regulatory T cells in the human immune system

Sakaguchi, S., Miyara, M., Costantino, C. M., & Hafler, D. A. (2010) · Nature reviews. Immunology · doi:10.1038/nri2785 · Cited by 2,524

Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor

Miyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C., Taflin, C., Heike, T., Valeyre, D., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.019 · Cited by 2,291

First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP:TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors

Shimizu, T., Powderly, J. D., Razak, A. A., LoRusso, P. M., Miller, K. D., Kao, S. C.-H., Kongpachith, S., Tribouley, C., Graham, M., Stoll, B. R., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1376551 · Cited by 15

CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs

Aly, M. G., Ibrahim, E. H., Karakizlis, H., Weimer, R., Opelz, G., Morath, C. P., Zeier, M., Ekpoom, N., & Daniel, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.716559 · Cited by 13

PTEN is required for human Treg suppression of costimulation in vitro

Lam, A. J., Haque, M., Ward‐Hartstonge, K. A., Uday, P., Wardell, C. M., Gillies, J. K., Speck, M., Mojibian, M., Geltink, R. I. K., & Levings, M. K. (2022) · European Journal of Immunology · doi:10.1002/eji.202249888 · Cited by 13

Fibroblasts and platelets: a face-to-face dialogue at the heart of cardiac fibrosis

Dufeys, C., Bodart, J., Bertrand, L., Beauloye, C., & Horman, S. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00559.2023 · Cited by 13

Systemically Administered Homing Peptide Targets Dystrophic Lesions and Delivers Transforming Growth Factor-β (TGFβ) Inhibitor to Attenuate Murine Muscular Dystrophy Pathology

Iqbal, A., May, U., Prince, S., Järvinen, T. A. H., & Heydemann, A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091506 · Cited by 12

IGHG, IGKC, and FCGR genes and endogenous antibody responses to GARP in patients with breast cancer and matched controls

Pandey, J. P., Namboodiri, A. M., Armeson, K. E., Iwasaki, M., Kasuga, Y., Hamada, G. S., & Tsugane, S. (2018) · Human Immunology · doi:10.1016/j.humimm.2018.06.001 · Cited by 11

Daratumumab Prevents Experimental Xenogeneic Graft-Versus-Host Disease by Skewing Proportions of T Cell Functional Subsets and Inhibiting T Cell Activation and Migration

Gao, Y., Shan, W., Gu, T., Zhang, J., Wu, Y., Li, X., Zeng, X., Zhou, H., Chen, Z. J., & Xiao, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.785774 · Cited by 9

TGF-β Signaling Prevents MHC Class II–Expressing Lymphatic Endothelial Cells from Reactivating Human Allogenic Memory CD4+ T Cells

Mężyk-Kopeć, R., Potin, L., Medellin, J. E. G., Salles, C. M., & Swartz, M. A. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200216 · Cited by 8

Characterization of human peripheral blood γδ T cells in patients with sepsis

Wang, X., Li, W., Zhu, D., Zhao, H., Chen, P., & Chen, X. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8615 · Cited by 8

Extracellular Vesicle–associated GARP/TGFβ:LAP Mediates “Infectious” Allo-tolerance

Burlingham, W. J., Jankowska−Gan, E., Fechner, J. H., Little, C. J., Wang, J., Hong, S., Molla, M. A., Sullivan, J. A., & Foley, D. P. (2023) · Transplantation Direct · doi:10.1097/txd.0000000000001475 · Cited by 8

Translating non-coding genetic associations into a better understanding of immune-mediated disease

Stankey, C. T., & Lee, J. C. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049790 · Cited by 9

Targeting immunosuppression by Tregs with monoclonal antibodies against GARP

Liénart, S., Stockis, J., Dedobbeleer, O., & Lucas, S. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1074379 · Cited by 7

Immuno-oncology moves beyond PD-1

Sheridan, C. (2015) · Nature Biotechnology · doi:10.1038/nbt0715-673 · Cited by 7

Targeting TGFβ docking receptor glycoprotein A repetitions predominant (GARP) via novel chimeric antigen receptor (CAR)-T cell platform to treat glioblastoma

Wu, B. X., Kreatsoulas, D. C., Çam, H., Bolyard, C. M., Chang, Y., Mandula, J. K., Welsh, P. W., Wang, Z., Li, A., Weltge, P., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf195 · Cited by 6

Foxp3+ Tregs in HCC immunity and immunotherapy

Feng, M., & Granito, A. (2026) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2026.05.004 · Cited by 6

Influencing factors and solution strategies of chimeric antigen receptor T-cell therapy (CAR–T) cell immunotherapy

Wang, Z., ZHOU, L., & WU, X. (2024) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2024.048564 · Cited by 6

Suppression of lysosome metabolism-meditated GARP/TGF-β1 complexes specifically depletes regulatory T cells to inhibit breast cancer metastasis

Ma, J., Chen, Y., Li, T., Cao, Y., Hu, B., Liu, Y., Zhang, Y., Li, X., Liu, J., Zhang, W., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03043-y · Cited by 5

Bidirectional anti-tumor and immunological strategies by targeting GARP–TGF-β axis in adult T-cell leukemia/lymphoma

Suzuki, K., Kusayanagi, S., Kuze, Y., Hata, M., Kozuma, S., Jimbo, K., Nannya, Y., Suzuki, Y., Uchimaru, K., & Yamagishi, M. (2025) · Leukemia · doi:10.1038/s41375-025-02725-0 · Cited by 7

GARP-expressing Tregs as a source of immunosuppressive TGF-β1 in human tumors

Meerbeeck, P. V., Maatougui, D., de Streel, G., Vaherto, N., Marbaix, É., Nana, F. A., den Eynde, M. V., Devaux, A., Carrasco, J., Noël, A., et al. (2025) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-025-04157-2 · Cited by 8

Regulatory T-cells and GARP expression are decreased in exercise-associated chikungunya viral arthritis flares

Dobbs, J. E., Tritsch, S. R., Encinales, L., Cadena, A., Suchowiecki, K., Simon, G. L., Mores, C. N., Insignares, S., Orozco, V. P. V., Ospino, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1007106 · Cited by 5

Tregs and Platelets Play Synergistic Roles in Tumor Immune Escape and Inflammatory Diseases

Gao, H., Zhou, Y., & Chen, X. (2022) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2023047234 · Cited by 7

Anti-GARP Antibodies Inhibit Release of TGF-β by Regulatory T Cells via Different Modes of Action, but Do Not Influence Their Function In Vitro

Igney, F. H., Ebenhoch, R., Schiele, F., & Nar, H. (2023) · ImmunoHorizons · doi:10.4049/immunohorizons.2200072 · Cited by 5

Discovery and preclinical evaluation of BPB-101: a novel triple functional bispecific antibody targeting GARP-TGF-β complex/SLC, free TGF-β and PD-L1

Xu, W., Xu, J., Li, P., Xu, D., Cheng, H., Zheng, H., Zhang, L., Liu, M., Ye, S., Jiang, M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1479399 · Cited by 5

Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host Disease

Belle, L., Fransolet, G., Somja, J., Binsfeld, M., Delvenne, P., Drion, P. V., Hannon, M., Beguin, Y. P., Ehx, G., & Baron, F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167997 · Cited by 4

New insight into GARP striking role in cancer progression: application for cancer therapy

Lahimchi, M. R., Eslami, M., & Yousefi, B. (2022) · Medical Oncology · doi:10.1007/s12032-022-01881-y · Cited by 4

Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop

Houot, R., Gaulard, P., Schreiber, R. D., Mellman, I., Lambotte, O., Coulie, P. G., Fest, T., Korman, A. J., Levy, R., Shipp, M. A., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1186323 · Cited by 4

Antibody-mediated TGF-β1 activation for the treatment of diseases caused by deleterious T cell activity

Lambert, F., Félix, J., Wautier, S., Dupré, E., Jamez, M., Michiels, C., Gaignage, M., Mariën, L., Lesage, M., van der Woning, B., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116061 · Cited by 5

Development of a humanized mouse model of graft-versus-host disease to assess human regulatory T cell function

Beguin, C., Kwan, O., Ehx, G., Humblet‐Baron, S., Köse, M. C., Dubois, S., Canti, L., Courtois, J., Daulne, C., Caers, J., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1717133 · Cited by 3

Spatial Distribution of Non-Immune Cells Expressing Glycoprotein A Repetitions Predominant in Human and Murine Metastatic Lymph Nodes

Rouaud, L., Baudin, L., Gautier‐Isola, M., Meerbeeck, P. V., Feyereisen, É., Blacher, S., van Baren, N., Kridelka, F., Lucas, S., & Noël, A. (2023) · Cancers · doi:10.3390/cancers15235621 · Cited by 3

Blocking GARP-mediated activation of TGF-β1 did not alter innate or adaptive immune responses to bacterial infection or protein immunization in mice

Gaignage, M., Zhang, X., Stockis, J., Dedobbeleer, O., Michiels, C., Cochez, P. M., Dumoutier, L., Coulie, P. G., & Lucas, S. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-03119-8 · Cited by 4

Netrin G1 Ligand is a new stromal immunomodulator that promotes pancreatic cancerPreprint

Costa, D. B. V., Francescone, R., Franco‐Barraza, J., Luong, T., Graves, M., de Aquino, A. M., Steele, N. G., Gardiner, J. C., dos Santos, S. A. A., Ogier, C., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.15.594354 · Cited by 3

Targeted radionuclide therapy against GARP expressing T regulatory cells after tumour priming with external beam radiotherapy in a murine syngeneic model

Bellaye, P., Dias, A. M. M., Vrigneaud, J., Bouchard, A., Moreau, M., Petitot, C., Bernhard, C., Claron, M., Froidurot, L., Morgand, V., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39543 · Cited by 2

Leucine rich repeat containing 32 accelerates tenogenic differentiation of tendon-derived stem cells and promotes Achilles tendon repair in rats

Kang, K., Cui, L., Zhang, Q., & Gao, S. (2022) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.22-0009 · Cited by 2

Harnessing Ubiquitin-Proteasome System-Related Genes to Identify Subtypes of Bladder Cancer and Reveal Immune Landscape

Shi, G., Zhou, X., Yang, F., & Wang, T. (2026) · American Journal of Men s Health · doi:10.1177/15579883251410519 · Cited by 1

More Velcro for the TGF-β1 straitjacket: A new antibody straps latent TGF-β1 to the matrix

Hinz, B. (2024) · Science Signaling · doi:10.1126/scisignal.ado5279 · Cited by 2

The Role of Tissue Factor-Positive Microparticles in Gynecological Cancer-Associated Disseminated Intravascular Coagulation: Molecular Mechanisms and Clinical Implications

Qureshi, M., Alam, M. T., & Unar, A. (2025) · Onco · doi:10.3390/onco5030033 · Cited by 1

Reigning in regulatory T-cell function

Konopacki, C., Plitas, G., & Rudensky, A. Y. (2015) · Nature Biotechnology · doi:10.1038/nbt.3285 · Cited by 1

Réduire l’immunosuppression par les Treg avec des anticorps monoclonaux anti-GARP

Lucas, S. (2015) · médecine/sciences · doi:10.1051/medsci/20153110007

TGFβ Signaling

Trendelenburg, A. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788015783-00001

PTEN is required for human Treg suppression of costimulationPreprint

Lam, A. J., Haque, M., Ward‐Hartstonge, K. A., Uday, P., Wardell, C. M., Gillies, J. K., Speck, M., Mojibian, M., Geltink, R. I. K., & Levings, M. K. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.06.483188

αv Integrin-Dependent TGFβ Activation in Cancer: A Brief Update

Marshall, J. F., Protopapa, P., & Allen, N. E. (2023) · Biology of extracellular matrix · doi:10.1007/978-3-031-23781-2_6

Evaluation of GARP immunohistochemical expression in papillary thyroid carcinoma

Atia, E. A. M. M., Sammour, S. A. E., Ibrahim, E. A.-S., Gabal, H. H. A., & Elgohary, S. A. (2024) · The Egyptian Journal of Otolaryngology · doi:10.1186/s43163-024-00658-6

Autocrine Transforming Growth Factor-β Signaling Promotes Cell Motility and Chemokine Secretion in an Angiomyolipoma-Derived Cell Model of Lymphangioleiomyomatosis

Moskal, A., Myrczek, R., Wawro, M., Ruiz-Auladell, L., Baiges, A., Garcia, I., Gonzalez, F. M., Pujana, M. Á., Kochan, J. A., Hinz, A., et al. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.04.019

La citocina TGF-β y su papel en la comunicación intercelular en el microambiente tumoral: Mecanismos de síntesis, secreción, activación y acción

Meza-Juárez, C. D., Color-Aparicio, V. M., Tecalco-Cruz, Á. C., & Macías‐Silva, M. (2025) · TIP Revista Especializada en Ciencias Químico-Biológicas · doi:10.22201/fesz.23958723e.2025.751

Control of adaptive immune responses by the TGFβ-activating avb8 integrins - implications for mucosal immune homeostasis and humoral immunity

This, S. (2020) · theses.fr (ABES) · doi:10.70675/7ae70a5bz1aaez4114z9217zcb3d1b957537

Utilisation de la thérapie cellulaire à l'aide de cellules dendritiques tolérogènes autologues en transplantation et dans les pathologies inflammatoires

Even, A. (2019) · theses.fr (ABES) · doi:10.70675/a37bd834z3ae0z4cc8za849ze912fa20b3a7

CD19SFv-CAR regulatory T-cell prevent acute graft versus host disease and improve chronic graft versus host disease

Loschi, M. L. (2018) · doi:10.70675/17e135c8z9669z4080z9651z611bcbd8df0a

Étude du rôle de l’expression de l’intégrine αvβ8 par les lymphocytes T régulateurs dans la réponse anti-tumorale

Lainé, A. (2019) · theses.fr (ABES) · doi:10.70675/d2c814ecz1cfaz4e8bzb907z44111907f2b7

Caractérisation et génération des lymphocytes B régulateurs à partir de cellules souches pluripotentes

Dubois, F. (2020) · theses.fr (ABES) · doi:10.70675/864f43c2z3334z4212z8509z71e31336cdcb

Exploring the interplay between chronic thrombo-inflammation and megakaryopoiesis in the development of microvascular lesions during vasculitis-associated glomerulonephritis

Douté, M. (2023) · theses.fr (ABES) · doi:10.70675/d318484dz389cz4199zbffdza78ab3163988

Le facteur de transcription Eomes régule les fonctions suppressives et la plasticité des cellules T régulatrices

Peroceschi, R. (2024) · theses.fr (ABES) · doi:10.70675/1253a351z345ez4a59za033z3f19256baba1

Platelet GARP-dependent activation of TGF-β1 limits inflammation and promotes cardiac repair after myocardial infarctionPreprint

Dufeys, C., Bodart, J., Ginion, A., Ambroise, J., Trusgnach, N., Ollivier, E. L., Bouzin, C., Brusa, D., Michiels, C., Senis, Y. A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.01.735778

Enhancing stability and function of induced regulatory T cells through membrane-anchored transforming growth factor-β1 and interleukin-10 secretion to protect against graft-vs-host disease

Zhang, S., Li, A., Li, S., Ji, X., Ji, X., Zhu, C., Chenli, Q., Zhang, X., Xu, J., & Zhang, S. (2026) · American Journal of Transplantation · doi:10.1016/j.ajt.2026.08.003

A fully human afucosylated anti-GARP antibody PBA-0111 drives anti-tumor immunity through combined ADCC induction and TGF-β1 pathway blockade

Spee, P., Litwin, M., Trojanowski, D., Burns, C., Dudek, A., Gołdyn, E., Sołtys, K., Sobecki, M., Świderska, A., Matyjaszczyk, I., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1921265

Regulatory T cell dysfunction and therapeutic advances in rheumatoid arthritis, psoriasis, vitiligo, and systemic lupus erythematosus

Liang, Y., Feng, H., Wang, Y., Li, J., & Niu, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1932889

Abstract B036: Monoclonal antibodies against GARP/TGF-β1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivo

Liénart, S., Cuende, J., Saunders, M. J., van der Woning, B., de Haard, H., Coulie, P. G., & Lucas, S. (2016) · Cancer Immunology Research · doi:10.1158/2326-6074.cricimteatiaacr15-b036

Blocking immunosuppression by human Tregs with antibodies against GArP/latent TGF-β1 complexes

Liénart, S. (2018) · DIAL (Catholic University of Leuven)

Targeting GARP on human Tregs: a novel approach for the immunotherapy of cancer?

Lucas, S., & PIVAC-19 (2019) · DIAL (Catholic University of Leuven)

Cancer immunotherapy with monoclonal antibodies blocking the GARP-dependent production of TGF-β1

de Streel, G. (2020) · Digital Access to Libraries

Anti-GARP Antibodies Inhibit Release of TGF-β by Regulatory T Cells via Different Modes of Action, but Do Not Influence Their Function In Vitro

Igney, F. H., Ebenhoch, R., Schiele, F., & Nar, H. (2023) · ImmunoHorizons · doi:10.4049/immunohorizons.2200072 · Cited by 5